Literature DB >> 12837836

Association between simian virus 40 DNA and lymphoma in the United kingdom.

Jane MacKenzie1, Katherine S Wilson, Jacqueline Perry, Alice Gallagher, Ruth F Jarrett.   

Abstract

Recent studies have reported the presence of simian virus 40 (SV40) DNA sequences in approximately 40% of tumor samples from non-Hodgkin's lymphoma (NHL) patients from the United States. We examined a series of 259 tumor and blood samples, including 152 NHL samples, from patients in the U.K. with lymphadenopathy and lymphoid leukemia for the presence of SV40 DNA using a highly sensitive quantitative polymerase chain reaction (PCR) assay and a consensus PCR assay capable of detecting the polyomaviruses SV40, BK, and JC. SV40 DNA sequences were not detected in any sample using either assay. Because the incidence of NHL is similar in the U.K. and the United States, this finding suggests that SV40 is unlikely to have an etiologic role in NHL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837836     DOI: 10.1093/jnci/95.13.1001

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  21 in total

1.  Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX.

Authors:  Sonia Toracchio; Claudia A Kozinetz; Deanna E Killen; Andrea M Sheehan; Eugenio I Banez; Michael M Ittmann; Vojtech Sroller; Janet S Butel
Journal:  J Clin Virol       Date:  2009-07-23       Impact factor: 3.168

2.  SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells.

Authors:  Grant R Campbell; Rachel S Bruckman; Yen-Lin Chu; Rodney N Trout; Stephen A Spector
Journal:  Cell Host Microbe       Date:  2018-10-18       Impact factor: 21.023

3.  Immunodetection of SV40 large T antigen in human central nervous system tumours.

Authors:  J Sabatier; E Uro-Coste; A Benouaich; S Boetto; M Gigaud; M Tremoulet; M-B Delisle; F Galateau-Sallé; P Brousset
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 4.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  JC virus antibody status underestimates infection rates.

Authors:  Joseph R Berger; Sidney A Houff; Julie Gurwell; Nubia Vega; Craig S Miller; Robert J Danaher
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

Review 6.  Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature.

Authors:  Christa S Zerbe; Beatriz E Marciano; Rohit K Katial; Carah B Santos; Nick Adamo; Amy P Hsu; Mary E Hanks; Dirk N Darnell; Martha M Quezado; Cathleen Frein; Lisa A Barnhart; Victoria L Anderson; Gulbu Uzel; Alexandra F Freeman; Andrea Lisco; Avindra Nath; Eugene O Major; Elizabeth P Sampaio; Steven M Holland
Journal:  Clin Infect Dis       Date:  2016-01-06       Impact factor: 9.079

7.  Internally controlled triplex quantitative PCR assay for human polyomaviruses JC and BK.

Authors:  Timothy J Dumonceaux; Christine Mesa; Alberto Severini
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

8.  SV40 lymphomagenesis in Syrian golden hamsters.

Authors:  Adrienne L McNees; Regis A Vilchez; Tiffany C Heard; Vojtech Sroller; Connie Wong; Alan J Herron; Mary J Hamilton; William C Davis; Janet S Butel
Journal:  Virology       Date:  2008-11-28       Impact factor: 3.616

9.  JC polyomavirus in the aetiology and pathophysiology of glial tumours.

Authors:  Tihomir Eftimov; Yavor Enchev; Iliya Tsekov; Plamen Simeonov; Zlatko Kalvatchev; Elitsa Encheva
Journal:  Neurosurg Rev       Date:  2015-11-12       Impact factor: 3.042

10.  Disease-modifying drugs for multiple sclerosis and JC virus expression.

Authors:  Craig S Miller; Sidney A Houff; Jason Hopper; Robert J Danaher; Julie A Gurwell; Yushun Lin; Nubia Vega; Joseph R Berger
Journal:  J Neurovirol       Date:  2012-05-15       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.